Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. S2 B
Azbazdar Y and De Robertis EM (2024)
|
Xla Wt + ctnnb1 MO
NF10.5 (in situ hybridization)
|
|
|
|
Fig. S3 E
Azbazdar Y and De Robertis EM (2024)
|
Xla Wt + ctnnb1 MO
NF10.5 (in situ hybridization)
|
|
|
|
Fig S2 DEFG
Azbazdar Y and De Robertis EM (2024)
|
Xla Wt + ctnnb1 MO
NF11.5 (RT-PCR)
|
|
|
|
Fig. S3 GHI
Azbazdar Y and De Robertis EM (2024)
|
Xla Wt + ctnnb1 MO
NF13 (RT-PCR)
|
|
|
|
Fig S3 B
Azbazdar Y and De Robertis EM (2024)
|
Xla Wt + ctnnb1 MO
NF28 (in situ hybridization)
|
|
|
|
Fig. J
Kreis J et al. (2021)
|
Xla Wt + ctnnb1 MO
NF10-11.5 (in situ hybridization)
|
|
|
|
Fig. 4C
Colozza G and De Robertis EM (2020)
|
Xla Wt + ctnnb1 MO
NF10 (RT-PCR)
|
|
|
|
Fig.2.C
Chen M et al. (2020)
|
Xla Wt + ctnnb1 + animal cap explant
NF10 (RT-PCR)
|
|
|
|
Fig.3.S1.A
Mukherjee S et al. (2020)
|
Xtr Wt + ctnnb1 MO
NF10.5 (immunohistochemistry)
|
|
|
|
Fig.5.Col.5
Mukherjee S et al. (2020)
|
Xtr Wt + ctnnb1 MO
NF10.5 (in situ hybridization)
|
|
|